Thursday, March 20, 2014

FDA Approval of Doxylamine–Pyridoxine Therapy for Use in Pregnancy — NEJM

Retweeted NEJM (@NEJM): History of morning sickness drug Bendectin shows how non–science-based decisions may affect a drug’s availability. http://t.co/kGRvjPIr2T

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/kGRvjPIr2T

No comments:

Post a Comment